Literature DB >> 18486045

Isoniazid.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18486045     DOI： 10.1016/S1472-9792(08)70011-8

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN： 1472-9792            Impact factor:   3.131


× No keyword cloud information.
  13 in total

1.  PharmGKB summary: isoniazid pathway, pharmacokinetics.

Authors:  Daniel J Klein; Sotiria Boukouvala; Ellen M McDonagh; Scott R Shuldiner; Nicola Laurieri; Caroline F Thorn; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2016-09       Impact factor: 2.089

Review 2.  Mining Fatty Acid Biosynthesis for New Antimicrobials.

Authors:  Christopher D Radka; Charles O Rock
Journal:  Annu Rev Microbiol       Date:  2022-06-01       Impact factor: 16.232

3.  Very-Rapidly Dissolving Printlets of Isoniazid Manufactured by SLS 3D Printing: In Vitro and In Vivo Characterization.

Authors:  Tahir Khuroo; Eman M Mohamed; Sathish Dharani; Canberk Kayalar; Tanil Ozkan; Mathew A Kuttolamadom; Ziyaur Rahman; Mansoor A Khan
Journal:  Mol Pharm       Date:  2022-06-01       Impact factor: 5.364

4.  Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence.

Authors:  Nuria Andreu; Taryn Fletcher; Nitya Krishnan; Siouxsie Wiles; Brian D Robertson
Journal:  J Antimicrob Chemother       Date:  2011-11-17       Impact factor: 5.790

5.  Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.

Authors:  Sivaranjani Namasivayam; Mamoudou Maiga; Wuxing Yuan; Vishal Thovarai; Diego L Costa; Lara R Mittereder; Matthew F Wipperman; Michael S Glickman; Amiran Dzutsev; Giorgio Trinchieri; Alan Sher
Journal:  Microbiome       Date:  2017-07-07       Impact factor: 14.650

6.  Multi-Methodological Quantitative Taste Assessment of Anti-Tuberculosis Drugs to Support the Development of Palatable Paediatric Dosage Forms.

Authors:  Alison V Keating; Jessica Soto; Claire Forbes; Min Zhao; Duncan Q M Craig; Catherine Tuleu
Journal:  Pharmaceutics       Date:  2020-04-17       Impact factor: 6.321

Review 7.  Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity.

Authors:  Juan David Guzman
Journal:  Molecules       Date:  2014-11-25       Impact factor: 4.411

8.  Antioxidant, Hepatoprotective Potential and Chemical Profiling of Propolis Ethanolic Extract from Kashmir Himalaya Region Using UHPLC-DAD-QToF-MS.

Authors:  Adil F Wali; Bharathi Avula; Zulfiqar Ali; Ikhlas A Khan; Ahlam Mushtaq; Muneeb U Rehman; Seema Akbar; Mubashir Hussain Masoodi
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

Review 9.  Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?

Authors:  Bruno L Abbadi; Valnês da Silva Rodrigues-Junior; Adilio da Silva Dadda; Kenia Pissinate; Anne D Villela; Maria M Campos; Luiz G de França Lopes; Cristiano V Bizarro; Pablo Machado; Eduardo H S Sousa; Luiz A Basso
Journal:  Front Microbiol       Date:  2018-05-01       Impact factor: 5.640

10.  Synthesis and Tuberculostatic Activity Evaluation of Novel Benzazoles with Alkyl, Cycloalkyl or Pyridine Moiety.

Authors:  Malwina Krause; Henryk Foks; Ewa Augustynowicz-Kopeć; Agnieszka Napiórkowska; Małgorzata Szczesio; Katarzyna Gobis
Journal:  Molecules       Date:  2018-04-23       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.